Associate Professor Mateusz Tajstra
Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
Membership:
FESC Member
Follow
Contributor content
Presentation
Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor
Presentation
Safety of stereotactic body radiation therapy in the presence of leadless Aveir pacemaker in the in vitro model
Presentation
Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies
Presentation
Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator
Presentation
Remote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure and implanted cardioverter-defibrillator or cardiac resynchronization therapy.
Presentation
Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.
Presentation
Comparison of long-term mortality of hybrid coronary revascularization vs. coronary artery bypass grafting. Three-years mortality of Hybrid Revascularization for Multivessel Coronary Artery Disease (H
Presentation
